RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 114 filers reported holding RELMADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $470,000 | +50.6% | 12,700 | 0.0% | 0.11% | +69.7% |
| Q2 2022 | $312,000 | -18.5% | 12,700 | -10.6% | 0.07% | -17.5% |
| Q1 2022 | $383,000 | +45.6% | 14,200 | 0.0% | 0.08% | +45.5% |
| Q4 2021 | $263,000 | -29.3% | 14,200 | 0.0% | 0.06% | -34.5% |
| Q3 2021 | $372,000 | -17.0% | 14,200 | +1.4% | 0.08% | -17.6% |
| Q2 2021 | $448,000 | -7.8% | 14,000 | -3.4% | 0.10% | -12.8% |
| Q1 2021 | $486,000 | -17.5% | 14,500 | -10.2% | 0.12% | -21.5% |
| Q4 2020 | $589,000 | -5.2% | 16,150 | -2.1% | 0.15% | -30.0% |
| Q3 2020 | $621,000 | -1.4% | 16,500 | -2.4% | 0.21% | -3.2% |
| Q2 2020 | $630,000 | +31.8% | 16,900 | +20.7% | 0.22% | -0.9% |
| Q1 2020 | $478,000 | -5.7% | 14,000 | +7.7% | 0.22% | +12.1% |
| Q4 2019 | $507,000 | – | 13,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |